NCT05742724View on ClinicalTrials.gov

The Pharmacokinetics of Single Dose Oral Tetrahydrocannabinol and Cannabidiol

PHASE1Active, not recruitingINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

January 11, 2024

Primary Completion Date

February 16, 2024

Study Completion Date

March 1, 2025

Conditions
CannabisChronic Kidney DiseasesDialysis
Interventions
DRUG

Tetrahydrocannabinol-Cannabidiol Combination

Oral THC 0.1mg/kg and CBD 2.5mg/kg

Trial Locations (1)

L8S 4A6

St. Joseph's Healthcare Hamilton, Hamilton

Sponsors
All Listed Sponsors
collaborator

Center for Medicinal Cannabis Research

OTHER

lead

McMaster University

OTHER